Gossamer Bio, Inc. financial data

Symbol
GOSS on Nasdaq
Industry
Pharmaceutical Preparations
Location
3013 Science Park, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 695 % +21.3%
Debt-to-equity 475 % -87.9%
Return On Equity -127 % +95.7%
Return On Assets -22.1 % +69.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 227M shares +0.53%
Common Stock, Shares, Outstanding 227M shares +0.53%
Entity Public Float 98M USD -81.9%
Common Stock, Value, Issued 23K USD 0%
Weighted Average Number of Shares Outstanding, Basic 226M shares +17.3%
Weighted Average Number of Shares Outstanding, Diluted 226M shares +17.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.48M USD
General and Administrative Expense 35.8M USD -15.2%
Operating Income (Loss) -72.8M USD +61.5%
Nonoperating Income (Expense) 4.47M USD +170%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -31.9M USD +20.2%
Income Tax Expense (Benefit) -1.13M USD
Net Income (Loss) Attributable to Parent -71.6M USD +61.8%
Earnings Per Share, Basic -0.11 USD/shares +93.7%
Earnings Per Share, Diluted -0.11 USD/shares +93.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.5M USD -65.5%
Marketable Securities, Current 299M USD +21.2%
Accounts Receivable, after Allowance for Credit Loss, Current 6.59M USD
Assets, Current 344M USD +0.81%
Property, Plant and Equipment, Net 302K USD -84.4%
Operating Lease, Right-of-Use Asset 6.03M USD +56.7%
Other Assets, Noncurrent 283K USD -56.4%
Assets 351M USD +0.85%
Accounts Payable, Current 3.06M USD +144%
Employee-related Liabilities, Current 10M USD +10.5%
Accrued Liabilities, Current 17.4M USD -0.22%
Contract with Customer, Liability, Current 20.3M USD
Liabilities, Current 51.1M USD +20.7%
Contract with Customer, Liability, Noncurrent 43.8M USD
Operating Lease, Liability, Noncurrent 4.59M USD +363%
Liabilities 297M USD +22%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.23M USD -261%
Retained Earnings (Accumulated Deficit) -1.24B USD -6.16%
Stockholders' Equity Attributable to Parent 54.1M USD -48.3%
Liabilities and Equity 351M USD +0.85%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -52.3M USD +1.3%
Net Cash Provided by (Used in) Financing Activities -2.56M USD -0.75%
Net Cash Provided by (Used in) Investing Activities 61.7M USD +607%
Common Stock, Shares Authorized 700M shares 0%
Common Stock, Shares, Issued 227M shares +0.53%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.75M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28.5M USD -65.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 367K USD -44.6%
Deferred Tax Assets, Valuation Allowance 221M USD +8.5%
Deferred Tax Assets, Gross 222M USD +7.92%
Operating Lease, Liability 6.34M USD +50.5%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -73.3M USD +60.9%
Lessee, Operating Lease, Liability, to be Paid 8.2M USD +86.8%
Property, Plant and Equipment, Gross 4.03M USD -42.5%
Operating Lease, Liability, Current 1.75M USD -45.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.4M USD +870%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.52M USD -55.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.86M USD +929%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.41M USD
Deferred Tax Assets, Operating Loss Carryforwards 123M USD -4.65%
Unrecognized Tax Benefits 13.7M USD +29.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.45M USD
Operating Lease, Payments 3.5M USD -2.78%
Depreciation, Depletion and Amortization 1M USD -42.6%
Share-based Payment Arrangement, Expense 27.8M USD +0.02%
Interest Expense 13.1M USD -5.56%